ArticleAndrology2026
Improvement of Mouse Spermatozoa Freezing at -80°C With Ascorbic Acid 2-Glucoside at Thawing Phase.
Article in Andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSperm cryopreservation is the most common method to maintain a great number of mutant mouse lines. However, the use of liquid nitrogen (LN
objectivesIn this work, freezing at -80°C is tested in combination with antioxidant, aimed at reducing membrane damage and oxidative stress. MATERIALS AND
methodsWildtype mouse line sperm were cryopreserved using the CPM method directly at -80°C. The effect of ascorbic acid 2-O-alpha-glucoside (AA2G) spermatozoa treatment, during thawing, was evaluated through a qualitative (motility, vitality, and acrosomal reaction using SCA System) and functional analysis (IVF and embryo development), after 1, 6, and 12 months.
resultsSperm motility and velocity parameters showed no significant differences between treated and control groups across both B6N and B6J strains over 12 months, though overall motility declined with time. Antioxidant treatment (AA2G) significantly improved sperm viability and in vitro fertilization (IVF) outcomes in both strains, particularly B6N, without affecting acrosome reaction rates or blastocyst development. DISCUSSION: Sperm cryopreservation at -80°C, while cost-effective, induces strain-dependent damage affecting sperm viability and fertility, particularly in B6J mice. Supplementation with the antioxidant AA2G during capacitation significantly improved post-thaw sperm survival and in vitro fertilization outcomes in both B6N and B6J strains, supporting its use in optimizing cryopreservation protocols without liquid nitrogen.
conclusionThese results may help to design new protocols or optimize those already validated by promoting the use of antioxidants in freezing at -80° as they have a significant effect on reducing oxidative stress, making spermatozoa qualitatively comparable to freezing in LN2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.